Rosetta Genomics Ltd. (ROSG) Starts Presentation at the Aegis Healthcare Conference

Rosetta Genomics Ltd. develops diagnostic tools for microRNAs, a group of genes produced using instructions encoded in DNA. The company offers diagnostic tests, including miRview mets2, a microRNA-based diagnostic used to identify 42 tumor types including carcinomas, soft tissue tumors, lymphoma, and other malignancies; and miRview meso used to differentiate mesothelioma, a cancer connected to asbestos exposure and other risk factors, from other carcinomas in the lung and pleura. For more information, visit the company’s website at www.rosettagenomics.com.